NETRI

NETRI develops technologies and microfluidic devices that accelerate the discovery and preclinical phases of a compound in development for pharmaceutical companies, CROs and university researchers interested in neurological disorders (Alzheimer's, Parkinson's, Huntington's).

The company offers both Neurofluidics kits and Neuroscope Labs services to improve understanding of the structural and functional mechanisms of neurological disorders. The Neurofluidics devices use high throughput microfluidic devices to explore specific modes of action and provide rodent / human organ on chip disease models. Neuroscope Labs offer expertise services for rapid and reproducible data acquisition on a neurological compound. NETRI's unique expertise and patented microfluidic engineering technologies enable its solutions to be high throughput and physiologically relevant at the network level.